^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Vulvar Cancer
    Drug:capecitabine (Thymidylate synthase inhibitor) +
    mitomycin (DNA synthesis inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A2 - Guideline
    New
    Source:
    NCCN
    Published date:
    09/22/2023
    Excerpt:
    Vulvar Cancer: SYSTEMIC THERAPY…Other Recommended Regimens…Capecitabine/mitomycin…